{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T03:58:33Z","timestamp":1790481513179,"version":"4.1.0"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T00:00:00Z","timestamp":1782518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000},"content-version":"vor","delay-in-days":89,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-59864-2","type":"journal-article","created":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T14:55:59Z","timestamp":1782572159000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Analysis of the coding transcriptome in NSCLC highlights variant-specific gene expression and signaling in CD74-ROS1 fusions"],"prefix":"10.1038","volume":"16","author":[{"given":"Jasmine","family":"Vargas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Olivieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5547-1406","authenticated-orcid":false,"given":"Georgios","family":"Pantouris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,27]]},"reference":[{"key":"59864_CR1","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1007\/s12672-024-01081-2","volume":"15","author":"Z Liu","year":"2024","unstructured":"Liu, Z., Chen, M., Zheng, W., Yuan, S. & Zhao, W. Insights into the prognostic value and immunological role of CD74 in pan-cancer. Discov Oncol 15, 222. https:\/\/doi.org\/10.1007\/s12672-024-01081-2 (2024).","journal-title":"Discov Oncol"},{"key":"59864_CR2","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1016\/j.bbamcr.2016.03.026","volume":"1863","author":"B Schr\u00f6der","year":"2016","unstructured":"Schr\u00f6der, B. The multifaceted roles of the invariant chain CD74\u2013More than just a chaperone. Biochim. Biophys. Acta 1863, 1269\u20131281. https:\/\/doi.org\/10.1016\/j.bbamcr.2016.03.026 (2016).","journal-title":"Biochim. Biophys. Acta"},{"key":"59864_CR3","doi-asserted-by":"publisher","first-page":"3483","DOI":"10.1002\/j.1460-2075.1986.tb04673.x","volume":"5","author":"M Strubin","year":"1986","unstructured":"Strubin, M., Berte, C. & Mach, B. Alternative splicing and alternative initiation of translation explain the four forms of the Ia antigen-associated invariant chain. EMBO J. 5, 3483\u20133488. https:\/\/doi.org\/10.1002\/j.1460-2075.1986.tb04673.x (1986).","journal-title":"EMBO J."},{"key":"59864_CR4","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1084\/jem.20030286","volume":"197","author":"L Leng","year":"2003","unstructured":"Leng, L. et al. MIF signal transduction initiated by binding to CD74. J. Exp. Med. 197, 1467\u20131476. https:\/\/doi.org\/10.1084\/jem.20030286 (2003).","journal-title":"J. Exp. Med."},{"key":"59864_CR5","doi-asserted-by":"publisher","first-page":"E577","DOI":"10.1073\/pnas.1102941108","volume":"108","author":"M Merk","year":"2011","unstructured":"Merk, M. et al. The D-dopachrome tautomerase (DDT) gene product is a cytokine and functional homolog of macrophage migration inhibitory factor (MIF). Proc. Natl. Acad. Sci. U S A 108, E577-585. https:\/\/doi.org\/10.1073\/pnas.1102941108 (2011).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"59864_CR6","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.immuni.2006.08.020","volume":"25","author":"X Shi","year":"2006","unstructured":"Shi, X. et al. CD44 is the signaling component of the macrophage migration inhibitory factor-CD74 receptor complex. Immunity 25, 595\u2013606. https:\/\/doi.org\/10.1016\/j.immuni.2006.08.020 (2006).","journal-title":"Immunity"},{"key":"59864_CR7","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1038\/nm1567","volume":"13","author":"J Bernhagen","year":"2007","unstructured":"Bernhagen, J. et al. MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment. Nat. Med. 13, 587\u2013596. https:\/\/doi.org\/10.1038\/nm1567 (2007).","journal-title":"Nat. Med."},{"key":"59864_CR8","doi-asserted-by":"publisher","first-page":"2749","DOI":"10.1016\/j.febslet.2009.07.058","volume":"583","author":"V Schwartz","year":"2009","unstructured":"Schwartz, V. et al. A functional heteromeric MIF receptor formed by CD74 and CXCR4. FEBS Lett 583, 2749\u20132757. https:\/\/doi.org\/10.1016\/j.febslet.2009.07.058 (2009).","journal-title":"FEBS Lett"},{"key":"59864_CR9","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1158\/1541-7786.Mcr-10-0288","volume":"8","author":"M Tarnowski","year":"2010","unstructured":"Tarnowski, M. et al. Macrophage migration inhibitory factor is secreted by rhabdomyosarcoma cells, modulates tumor metastasis by binding to CXCR4 and CXCR7 receptors and inhibits recruitment of cancer-associated fibroblasts. Mol. Cancer Res. 8, 1328\u20131343. https:\/\/doi.org\/10.1158\/1541-7786.Mcr-10-0288 (2010).","journal-title":"Mol. Cancer Res."},{"key":"59864_CR10","doi-asserted-by":"publisher","first-page":"4497","DOI":"10.1096\/fj.15-273904","volume":"29","author":"S Alampour-Rajabi","year":"2015","unstructured":"Alampour-Rajabi, S. et al. MIF interacts with CXCR7 to promote receptor internalization, ERK1\/2 and ZAP-70 signaling, and lymphocyte chemotaxis. FASEB J. 29, 4497\u20134511. https:\/\/doi.org\/10.1096\/fj.15-273904 (2015).","journal-title":"FASEB J."},{"key":"59864_CR11","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.cellsig.2005.06.013","volume":"18","author":"H Lue","year":"2006","unstructured":"Lue, H. et al. Rapid and transient activation of the ERK MAPK signalling pathway by macrophage migration inhibitory factor (MIF) and dependence on JAB1\/CSN5 and Src kinase activity. Cell Signal 18, 688\u2013703. https:\/\/doi.org\/10.1016\/j.cellsig.2005.06.013 (2006).","journal-title":"Cell Signal"},{"key":"59864_CR12","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/j.cyto.2012.07.037","volume":"60","author":"K Ishimoto","year":"2012","unstructured":"Ishimoto, K. et al. D-dopachrome tautomerase promotes IL-6 expression and inhibits adipogenesis in preadipocytes. Cytokine 60, 772\u2013777. https:\/\/doi.org\/10.1016\/j.cyto.2012.07.037 (2012).","journal-title":"Cytokine"},{"key":"59864_CR13","doi-asserted-by":"publisher","first-page":"2784","DOI":"10.1074\/jbc.M703265200","volume":"283","author":"Y Gore","year":"2008","unstructured":"Gore, Y. et al. Macrophage migration inhibitory factor induces B cell survival by activation of a CD74-CD44 receptor complex. J Biol Chem 283, 2784\u20132792. https:\/\/doi.org\/10.1074\/jbc.M703265200 (2008).","journal-title":"J Biol Chem"},{"key":"59864_CR14","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s13578-022-00867-7","volume":"12","author":"H Li","year":"2022","unstructured":"Li, H. et al. D-dopachrome tautomerase drives astroglial inflammation via NF-\u03baB signaling following spinal cord injury. Cell Biosci. 12, 128. https:\/\/doi.org\/10.1186\/s13578-022-00867-7 (2022).","journal-title":"Cell Biosci."},{"key":"59864_CR15","doi-asserted-by":"publisher","first-page":"5046","DOI":"10.1038\/sj.onc.1210318","volume":"26","author":"H Lue","year":"2007","unstructured":"Lue, H. et al. Macrophage migration inhibitory factor (MIF) promotes cell survival by activation of the Akt pathway and role for CSN5\/JAB1 in the control of autocrine MIF activity. Oncogene 26, 5046\u20135059. https:\/\/doi.org\/10.1038\/sj.onc.1210318 (2007).","journal-title":"Oncogene"},{"key":"59864_CR16","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.cellsig.2010.08.013","volume":"23","author":"H Lue","year":"2011","unstructured":"Lue, H., Dewor, M., Leng, L., Bucala, R. & Bernhagen, J. Activation of the JNK signalling pathway by macrophage migration inhibitory factor (MIF) and dependence on CXCR4 and CD74. Cell Signal 23, 135\u2013144. https:\/\/doi.org\/10.1016\/j.cellsig.2010.08.013 (2011).","journal-title":"Cell Signal"},{"key":"59864_CR17","doi-asserted-by":"publisher","first-page":"3540","DOI":"10.1172\/JCI73061","volume":"124","author":"D Qi","year":"2014","unstructured":"Qi, D. et al. The vestigial enzyme D-dopachrome tautomerase protects the heart against ischemic injury. J. Clin. Investig. 124, 3540\u20133550. https:\/\/doi.org\/10.1172\/JCI73061 (2014).","journal-title":"J. Clin. Investig."},{"key":"59864_CR18","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s12974-021-02186-z","volume":"18","author":"H Ji","year":"2021","unstructured":"Ji, H. et al. D-dopachrome tautomerase activates COX2\/PGE2 pathway of astrocytes to mediate inflammation following spinal cord injury. J. Neuroinflammation 18, 130. https:\/\/doi.org\/10.1186\/s12974-021-02186-z (2021).","journal-title":"J. Neuroinflammation"},{"key":"59864_CR19","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1073\/pnas.1612195114","volume":"114","author":"N Gil-Yarom","year":"2017","unstructured":"Gil-Yarom, N. et al. CD74 is a novel transcription regulator. Proc. Natl Acad. Sci. 114, 562\u2013567. https:\/\/doi.org\/10.1073\/pnas.1612195114 (2017).","journal-title":"Proc. Natl Acad. Sci."},{"key":"59864_CR20","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.bbcan.2008.07.006","volume":"1795","author":"J Acquaviva","year":"2009","unstructured":"Acquaviva, J., Wong, R. & Charest, A. The multifaceted roles of the receptor tyrosine kinase ROS in development and cancer. Biochim. Biophys. Acta 1795, 37\u201352. https:\/\/doi.org\/10.1016\/j.bbcan.2008.07.006 (2009).","journal-title":"Biochim. Biophys. Acta"},{"key":"59864_CR21","doi-asserted-by":"publisher","first-page":"4799","DOI":"10.1073\/pnas.87.12.4799","volume":"87","author":"C Birchmeier","year":"1990","unstructured":"Birchmeier, C., O\u2019Neill, K., Riggs, M. & Wigler, M. Characterization of ROS1 cDNA from a human glioblastoma cell line. Proc. Natl. Acad. Sci. U S A 87, 4799\u20134803. https:\/\/doi.org\/10.1073\/pnas.87.12.4799 (1990).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"59864_CR22","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s41571-020-0408-9","volume":"18","author":"A Drilon","year":"2021","unstructured":"Drilon, A. et al. ROS1-dependent cancers - biology, diagnostics and therapeutics. Nat. Rev. Clin. Oncol. 18, 35\u201355. https:\/\/doi.org\/10.1038\/s41571-020-0408-9 (2021).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"59864_CR23","doi-asserted-by":"publisher","first-page":"4677","DOI":"10.1016\/j.molcel.2024.10.017","volume":"84","author":"G Cerutti","year":"2024","unstructured":"Cerutti, G. et al. Structures and pH-dependent dimerization of the sevenless receptor tyrosine kinase. Mol. Cell 84, 4677-4690.e4676. https:\/\/doi.org\/10.1016\/j.molcel.2024.10.017 (2024).","journal-title":"Mol. Cell"},{"key":"59864_CR24","doi-asserted-by":"publisher","first-page":"22191","DOI":"10.1038\/s41598-024-71687-7","volume":"14","author":"K Jones","year":"2024","unstructured":"Jones, K. et al. Novel insight into mechanisms of ROS1 catalytic activation via loss of the extracellular domain. Sci Rep 14, 22191. https:\/\/doi.org\/10.1038\/s41598-024-71687-7 (2024).","journal-title":"Sci Rep"},{"key":"59864_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtocrr.2020.100048","volume":"1","author":"SI Ou","year":"2020","unstructured":"Ou, S. I. & Nagasaka, M. A catalog of 5\u2019 fusion partners in ROS1-positive NSCLC Circa 2020. JTO Clin. Res. Rep. 1, 100048. https:\/\/doi.org\/10.1016\/j.jtocrr.2020.100048 (2020).","journal-title":"JTO Clin. Res. Rep."},{"key":"59864_CR26","doi-asserted-by":"publisher","first-page":"9270","DOI":"10.1073\/pnas.84.24.9270","volume":"84","author":"C Birchmeier","year":"1987","unstructured":"Birchmeier, C., Sharma, S. & Wigler, M. Expression and rearrangement of the ROS1 gene in human glioblastoma cells. Proc. Natl. Acad. Sci. U S A 84, 9270\u20139274. https:\/\/doi.org\/10.1073\/pnas.84.24.9270 (1987).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"59864_CR27","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1002\/gcc.10207","volume":"37","author":"A Charest","year":"2003","unstructured":"Charest, A. et al. Fusion of FIG to the receptor tyrosine kinase ROS in a glioblastoma with an interstitial del(6)(q21q21). Genes Chromosomes Cancer 37, 58\u201371. https:\/\/doi.org\/10.1002\/gcc.10207 (2003).","journal-title":"Genes Chromosomes Cancer"},{"key":"59864_CR28","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1200\/jco.2011.35.6345","volume":"30","author":"K Bergethon","year":"2012","unstructured":"Bergethon, K. et al. ROS1 rearrangements define a unique molecular class of lung cancers. J. Clin. Oncol. 30, 863\u2013870. https:\/\/doi.org\/10.1200\/jco.2011.35.6345 (2012).","journal-title":"J. Clin. Oncol."},{"key":"59864_CR29","doi-asserted-by":"publisher","first-page":"7473","DOI":"10.1158\/0008-5472.Can-06-1193","volume":"66","author":"A Charest","year":"2006","unstructured":"Charest, A. et al. ROS fusion tyrosine kinase activates a SH2 domain-containing phosphatase-2\/phosphatidylinositol 3-kinase\/mammalian target of rapamycin signaling axis to form glioblastoma in mice. Can. Res. 66, 7473\u20137481. https:\/\/doi.org\/10.1158\/0008-5472.Can-06-1193 (2006).","journal-title":"Can. Res."},{"key":"59864_CR30","doi-asserted-by":"publisher","first-page":"2932","DOI":"10.1158\/1078-0432.Ccr-19-3321","volume":"26","author":"H Sato","year":"2020","unstructured":"Sato, H. et al. MAPK pathway alterations correlate with poor survival and drive resistance to therapy in patients with lung cancers driven by ROS1 fusions. Clin Cancer Res 26, 2932\u20132945. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-19-3321 (2020).","journal-title":"Clin Cancer Res"},{"key":"59864_CR31","doi-asserted-by":"publisher","first-page":"11107","DOI":"10.1074\/jbc.M108166200","volume":"277","author":"KT Nguyen","year":"2002","unstructured":"Nguyen, K. T. et al. The role of phosphatidylinositol 3-kinase, Rho family GTPases, and STAT3 in Ros-induced cell transformation. J. Biol. Chem. 277, 11107\u201311115. https:\/\/doi.org\/10.1074\/jbc.M108166200 (2002).","journal-title":"J. Biol. Chem."},{"key":"59864_CR32","doi-asserted-by":"publisher","first-page":"28065","DOI":"10.1074\/jbc.273.43.28065","volume":"273","author":"CS Zong","year":"1998","unstructured":"Zong, C. S., Zeng, L., Jiang, Y., Sadowski, H. B. & Wang, L.-H. Stat3 Plays an important role in oncogenic Ros- and insulin-like growth factor I receptor-induced anchorage-independent growth. J. Biol. Chem. 273, 28065\u201328072. https:\/\/doi.org\/10.1074\/jbc.273.43.28065 (1998).","journal-title":"J. Biol. Chem."},{"key":"59864_CR33","doi-asserted-by":"publisher","first-page":"9212","DOI":"10.1128\/mcb.20.24.9212-9224.2000","volume":"20","author":"L Zeng","year":"2000","unstructured":"Zeng, L. et al. Vav3 mediates receptor protein tyrosine kinase signaling, regulates GTPase activity, modulates cell morphology, and induces cell transformation. Mol Cell Biol 20, 9212\u20139224. https:\/\/doi.org\/10.1128\/mcb.20.24.9212-9224.2000 (2000).","journal-title":"Mol Cell Biol"},{"key":"59864_CR34","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1093\/oncolo\/oyae205","volume":"29","author":"MC Boulanger","year":"2024","unstructured":"Boulanger, M. C., Schneider, J. L. & Lin, J. J. Advances and future directions in ROS1 fusion-positive lung cancer. Oncologist 29, 943\u2013956. https:\/\/doi.org\/10.1093\/oncolo\/oyae205 (2024).","journal-title":"Oncologist"},{"key":"59864_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/ijms242115981","volume":"24","author":"J Vargas","year":"2023","unstructured":"Vargas, J. & Pantouris, G. Analysis of CD74 occurrence in oncogenic fusion proteins. Int. J. Mol. Sci. 24, 15981 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"59864_CR36","doi-asserted-by":"publisher","first-page":"8529","DOI":"10.3390\/ijms21228529","volume":"21","author":"J Esteban-Villarrubia","year":"2020","unstructured":"Esteban-Villarrubia, J. et al. Tyrosine kinase receptors in oncology. Int. J. Mol. Sci. 21, 8529. https:\/\/doi.org\/10.3390\/ijms21228529 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"59864_CR37","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1056\/NEJMoa1406766","volume":"371","author":"AT Shaw","year":"2014","unstructured":"Shaw, A. T. et al. Crizotinib in ROS1-rearranged non-small-cell lung cancer. N Engl. J. Med. 371, 1963\u20131971. https:\/\/doi.org\/10.1056\/NEJMoa1406766 (2014).","journal-title":"N Engl. J. Med."},{"key":"59864_CR38","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/s1470-2045(19)30690-4","volume":"21","author":"A Drilon","year":"2020","unstructured":"Drilon, A. et al. Entrectinib in ROS1 fusion-positive non-small-cell lung cancer: Integrated analysis of three phase 1-2 trials. Lancet Oncol. 21, 261\u2013270. https:\/\/doi.org\/10.1016\/s1470-2045(19)30690-4 (2020).","journal-title":"Lancet Oncol."},{"key":"59864_CR39","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1056\/NEJMoa2302299","volume":"390","author":"A Drilon","year":"2024","unstructured":"Drilon, A. et al. Repotrectinib in ROS1 fusion\u2013positive non\u2013small-cell lung cancer. N. Engl. J. Med. 390, 118\u2013131. https:\/\/doi.org\/10.1056\/NEJMoa2302299 (2024).","journal-title":"N. Engl. J. Med."},{"key":"59864_CR40","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.jtho.2023.12.009","volume":"19","author":"W Li","year":"2024","unstructured":"Li, W. et al. CD74\/SLC34A2-ROS1 fusion variants involving the transmembrane region predict poor response to Crizotinib in NSCLC independent of TP53 mutations. J. Thorac. Oncol. 19, 613\u2013625. https:\/\/doi.org\/10.1016\/j.jtho.2023.12.009 (2024).","journal-title":"J. Thorac. Oncol."},{"key":"59864_CR41","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/nm.2658","volume":"18","author":"K Takeuchi","year":"2012","unstructured":"Takeuchi, K. et al. RET, ROS1 and ALK fusions in lung cancer. Nat Med 18, 378\u2013381. https:\/\/doi.org\/10.1038\/nm.2658 (2012).","journal-title":"Nat Med"},{"key":"59864_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1021342","volume":"12","author":"X Zhang","year":"2022","unstructured":"Zhang, X. et al. Case report: A novel reciprocal ROS1-CD74 fusion in a NSCLC patient partially benefited from sequential tyrosine kinase inhibitors treatment. Front. Oncol. 12, 1021342. https:\/\/doi.org\/10.3389\/fonc.2022.1021342 (2022).","journal-title":"Front. Oncol."},{"key":"59864_CR43","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1093\/annonc\/mdt071","volume":"24","author":"W Cai","year":"2013","unstructured":"Cai, W. et al. ROS1 fusions in Chinese patients with non-small-cell lung cancer. Ann. Oncol. 24, 1822\u20131827. https:\/\/doi.org\/10.1093\/annonc\/mdt071 (2013).","journal-title":"Ann. Oncol."},{"key":"59864_CR44","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1097\/jto.0000000000000232","volume":"9","author":"YF Chen","year":"2014","unstructured":"Chen, Y. F. et al. Clinical and the prognostic characteristics of lung adenocarcinoma patients with ROS1 fusion in comparison with other driver mutations in East Asian populations. J. Thorac. Oncol. 9, 1171\u20131179. https:\/\/doi.org\/10.1097\/jto.0000000000000232 (2014).","journal-title":"J. Thorac. Oncol."},{"key":"59864_CR45","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1002\/1878-0261.13468","volume":"17","author":"A Gim\u00e9nez-Capit\u00e1n","year":"2023","unstructured":"Gim\u00e9nez-Capit\u00e1n, A. et al. Detecting ALK, ROS1, and RET fusions and the MET\u0394ex14 splicing variant in liquid biopsies of non-small-cell lung cancer patients using RNA-based techniques. Mol. Oncol. 17, 1884\u20131897. https:\/\/doi.org\/10.1002\/1878-0261.13468 (2023).","journal-title":"Mol. Oncol."},{"key":"59864_CR46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0056010","volume":"8","author":"Y Arai","year":"2013","unstructured":"Arai, Y. et al. Mouse model for ROS1-rearranged lung cancer. PLoS ONE 8, e56010. https:\/\/doi.org\/10.1371\/journal.pone.0056010 (2013).","journal-title":"PLoS ONE"},{"key":"59864_CR47","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s10014-018-0330-3","volume":"36","author":"Y Nakano","year":"2019","unstructured":"Nakano, Y. et al. Identification of a novel KLC1\u2013ROS1 fusion in a case of pediatric low-grade localized glioma. Brain Tumor Pathol. 36, 14\u201319. https:\/\/doi.org\/10.1007\/s10014-018-0330-3 (2019).","journal-title":"Brain Tumor Pathol."},{"key":"59864_CR48","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.1016\/j.cell.2022.04.016","volume":"185","author":"MR Puno","year":"2022","unstructured":"Puno, M. R. & Lima, C. D. Structural basis for RNA surveillance by the human nuclear exosome targeting (NEXT) complex. Cell 185, 2132\u20132147. https:\/\/doi.org\/10.1016\/j.cell.2022.04.016 (2022).","journal-title":"Cell"},{"key":"59864_CR49","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202217367","volume":"15","author":"SR Iyer","year":"2023","unstructured":"Iyer, S. R. et al. Discovery of oncogenic ROS1 missense mutations with sensitivity to tyrosine kinase inhibitors. EMBO Mol. Med. 15, e17367. https:\/\/doi.org\/10.15252\/emmm.202217367 (2023).","journal-title":"EMBO Mol. Med."},{"key":"59864_CR50","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.phrs.2017.04.022","volume":"121","author":"R Roskoski Jr.","year":"2017","unstructured":"Roskoski, R. Jr. ROS1 protein-tyrosine kinase inhibitors in the treatment of ROS1 fusion protein-driven non-small cell lung cancers. Pharmacol. Res. 121, 202\u2013212. https:\/\/doi.org\/10.1016\/j.phrs.2017.04.022 (2017).","journal-title":"Pharmacol. Res."},{"key":"59864_CR51","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1111\/febs.17032","volume":"291","author":"X Xu","year":"2024","unstructured":"Xu, X. et al. CD74\u2013ROS1 L2026M mutant enhances autophagy through the MEK\/ERK pathway to promote invasion, metastasis and crizotinib resistance in non-small cell lung cancer cells. FEBS J. 291, 1199\u20131219. https:\/\/doi.org\/10.1111\/febs.17032 (2024).","journal-title":"FEBS J."},{"key":"59864_CR52","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.canlet.2018.02.032","volume":"422","author":"W Gou","year":"2018","unstructured":"Gou, W. et al. CD74-ROS1 G2032R mutation transcriptionally up-regulates Twist1 in non-small cell lung cancer cells leading to increased migration, invasion, and resistance to crizotinib. Cancer Lett. 422, 19\u201328. https:\/\/doi.org\/10.1016\/j.canlet.2018.02.032 (2018).","journal-title":"Cancer Lett."},{"key":"59864_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2022.110497","volume":"101","author":"R Sun","year":"2023","unstructured":"Sun, R. et al. Construction of crizotinib resistant models with CD74-ROS1 D2033N and CD74-ROS1 S1986F point mutations to explore resistance mechanism and treatment strategy. Cell. Signal. 101, 110497. https:\/\/doi.org\/10.1016\/j.cellsig.2022.110497 (2023).","journal-title":"Cell. Signal."},{"key":"59864_CR54","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1006\/abio.1995.1020","volume":"224","author":"CE Mitchell","year":"1995","unstructured":"Mitchell, C. E., Belinsky, S. A. & Lechner, J. F. Detection and quantitation of mutant K-ras Codon 12 restriction fragments by capillary electrophoresis. Anal. Biochem. 224, 148\u2013153. https:\/\/doi.org\/10.1006\/abio.1995.1020 (1995).","journal-title":"Anal. Biochem."},{"key":"59864_CR55","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/j.jtho.2017.01.004","volume":"12","author":"JJ Lin","year":"2017","unstructured":"Lin, J. J. et al. ROS1 fusions rarely overlap with other oncogenic drivers in non-small cell lung cancer. J. Thorac. Oncol. 12, 872\u2013877. https:\/\/doi.org\/10.1016\/j.jtho.2017.01.004 (2017).","journal-title":"J. Thorac. Oncol."},{"key":"59864_CR56","doi-asserted-by":"publisher","first-page":"3209","DOI":"10.1158\/0008-5472.Can-14-3042","volume":"75","author":"Z Qu","year":"2015","unstructured":"Qu, Z. et al. Interleukin-6 prevents the initiation but enhances the progression of lung cancer. Cancer Res. 75, 3209\u20133215. https:\/\/doi.org\/10.1158\/0008-5472.Can-14-3042 (2015).","journal-title":"Cancer Res."},{"key":"59864_CR57","doi-asserted-by":"publisher","first-page":"2775","DOI":"10.1038\/jid.2015.204","volume":"135","author":"K Tanese","year":"2015","unstructured":"Tanese, K. et al. Cell surface CD74-MIF interactions drive melanoma survival in response to interferon-\u03b3. J. Invest. Dermatol. 135, 2775\u20132784. https:\/\/doi.org\/10.1038\/jid.2015.204 (2015).","journal-title":"J. Invest. Dermatol."},{"key":"59864_CR58","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241612993","volume":"24","author":"WC Hong","year":"2023","unstructured":"Hong, W. C. et al. CD74 promotes a Pro-inflammatory tumor microenvironment by inducing S100A8 and S100A9 secretion in pancreatic cancer. Int. J. Mol. Sci. 24, 12993 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"59864_CR59","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.18632\/oncotarget.2671","volume":"6","author":"J Li","year":"2015","unstructured":"Li, J. et al. Reciprocal activation between IL-6\/STAT3 and NOX4\/Akt signalings promotes proliferation and survival of non-small cell lung cancer cells. Oncotarget 6, 1031\u20131048. https:\/\/doi.org\/10.18632\/oncotarget.2671 (2015).","journal-title":"Oncotarget"},{"key":"59864_CR60","doi-asserted-by":"publisher","first-page":"2585","DOI":"10.3892\/ol.2020.11394","volume":"19","author":"Y Gu","year":"2020","unstructured":"Gu, Y., Mohammad, I. S. & Liu, Z. Overview of the STAT\u20113 signaling pathway in cancer and the development of specific inhibitors (Review). Oncol. Lett. 19, 2585\u20132594. https:\/\/doi.org\/10.3892\/ol.2020.11394 (2020).","journal-title":"Oncol. Lett."},{"key":"59864_CR61","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11101618","author":"C Braicu","year":"2019","unstructured":"Braicu, C. et al. A comprehensive review on MAPK: A promising therapeutic target in cancer. Cancers (Basel) https:\/\/doi.org\/10.3390\/cancers11101618 (2019).","journal-title":"Cancers (Basel)"},{"key":"59864_CR62","doi-asserted-by":"publisher","first-page":"3764","DOI":"10.1158\/0008-5472.CAN-11-3990","volume":"72","author":"HJ Jun","year":"2012","unstructured":"Jun, H. J. et al. The oncogenic lung cancer fusion kinase CD74-ROS activates a novel invasiveness pathway through E-Syt1 phosphorylation. Cancer Res. 72, 3764\u20133774. https:\/\/doi.org\/10.1158\/0008-5472.CAN-11-3990 (2012).","journal-title":"Cancer Res."},{"key":"59864_CR63","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/978-1-0716-5056-1_20","volume":"3002","author":"J Vargas","year":"2026","unstructured":"Vargas, J. & Pantouris, G. Stable transfection of CD74 gene variants into A549 lung adenocarcinoma cell line. Methods Mol. Biol. 3002, 227\u2013238. https:\/\/doi.org\/10.1007\/978-1-0716-5056-1_20 (2026).","journal-title":"Methods Mol. Biol."},{"key":"59864_CR64","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-13-134","volume":"13","author":"J Ye","year":"2012","unstructured":"Ye, J. et al. Primer-BLAST: a tool to design target-specific primers for polymerase chain reaction. BMC Bioinformatics 13, 134. https:\/\/doi.org\/10.1186\/1471-2105-13-134 (2012).","journal-title":"BMC Bioinformatics"},{"key":"59864_CR65","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.1923","volume":"9","author":"B Langmead","year":"2012","unstructured":"Langmead, B. & Salzberg, S. L. Fast gapped-read alignment with Bowtie 2. Nat. Methods 9, 357\u2013359. https:\/\/doi.org\/10.1038\/nmeth.1923 (2012).","journal-title":"Nat. Methods"},{"key":"59864_CR66","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","volume":"30","author":"Y Liao","year":"2014","unstructured":"Liao, Y., Smyth, G. K. & Shi, W. FeatureCounts: An efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics 30, 923\u2013930. https:\/\/doi.org\/10.1093\/bioinformatics\/btt656 (2014).","journal-title":"Bioinformatics"},{"key":"59864_CR67","unstructured":"Simon, A. FastQC: a quality control tool for high throughput sequence data. Version 0.10 1 (2010)."},{"key":"59864_CR68","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol 15, 550. https:\/\/doi.org\/10.1186\/s13059-014-0550-8 (2014).","journal-title":"Genome Biol"},{"key":"59864_CR69","first-page":"2825","volume":"12","author":"F Pedregosa","year":"2011","unstructured":"Pedregosa, F. et al. Scikit-learn: Machine learning in python. J. Mach. Learn. Res. 12, 2825\u20132830 (2011).","journal-title":"J. Mach. Learn. Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-59864-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-59864-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-59864-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T03:29:22Z","timestamp":1790479762000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-59864-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,27]]},"references-count":69,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["59864"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-59864-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,27]]},"assertion":[{"value":"19 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"29624"}}